WPG Advisers’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129K Buy
3,026
+1,110
+58% +$60.3K 0.08% 159
2026
Q1
$120K Buy
1,916
+203
+12% +$16.2K 0.09% 127
2025
Q4
$163K Sell
1,713
-70
-4% -$6.86K 0.12% 111
2025
Q3
$174K Buy
1,783
+72
+4% +$7.46K 0.14% 102
2025
Q2
$184K Sell
1,711
-112
-6% -$11.3K 0.16% 92
2025
Q1
$184K Sell
1,823
-136
-7% -$13.7K 0.17% 91
2024
Q4
$175K Buy
+1,959
New +$172K 0.16% 109

Other funds holding BSX

WPG Advisers's BSX Position: Q2 2026 in Review

WPG Advisers increased its Boston Scientific (BSX) stake by 58% in Q2 2026, buying an estimated $60.3K and bringing the position to 3,026 shares worth $129K. The position accounts for 0.08% of the portfolio, ranked #159.

WPG Advisers first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $184K in Q1 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • WPG Advisers held 3,026 shares of Boston Scientific worth $129K as of Q2 2026.
  • WPG Advisers bought 1,110 Boston Scientific shares in Q2 2026, an estimated $60.3K.
  • Boston Scientific made up 0.08% of WPG Advisers's portfolio in Q2 2026, its #159 holding.
  • WPG Advisers first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Boston Scientific position peaked at $184K in Q1 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.